Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of methionine sulfoximine to treat diseases caused by an inflammatory cytokine response

Use of methionine sulfoximine to treat diseases caused by an inflammatory cytokine response

US Patent 11207284 · Granted Dec 28, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Second generation inhibitors of mitochondrial permeability transition pore with 2025
Method for programming a field programmable gate array and network configuration2021
Small molecule inhibitors of the mitochondrial permeability transition pore (mtP2020
Use of methionine sulfoximine to treat diseases caused by an inflammatory cytoki2017
Use of methionine sulfoximine to treat diseases caused by an inflammatory cytoki2017
Use of methionine sulfoximine to treat acute liver failure and other diseases ca2015
Use of methionine sulfoximine to treat acute liver failure and other diseases ca2015
Use of methionine sulfoximine to treat acute liver failure and other diseases ca2013
Use of methionine sulfoximine to treat acute liver failure and other diseases ca2013
Non-immunosuppressive cyclosporin for treatment of Ullrich congenital muscular d2013
Operating head2013
Treatment of polyglutamine disorders caused by expanding genomic CAG nucleotides2011